Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CCL vs MRNA✓SelectedUSD · MRNACCL vs MRNA performance historyLatest closeAs of+2.88%11/18
Stock and ETF performance explorer

CCL vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+17.5%
MRNA return
+293.7%
Excess return
-276.2%
Maximum drawdown
-29.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+2.9%-4.8%+7.7%+2.9%
7D-5.6%-20.9%+15.3%-5.4%
30D+10.1%-13.3%+23.4%+10.3%
3M+6.8%+212.6%-205.8%+7.7%
6M+17.5%+309.0%-291.5%+2.3%
All+17.5%+293.7%-276.2%+2.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling